WAVE LIFE SCIENCES LTD. Payments for Restructuring
WAVE LIFE SCIENCES LTD. (WVE) reported Payments for Restructuring of $200.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2020-11-09
- WAVE LIFE SCIENCES LTD. payments for restructuring for the quarter ending 2020-09-30 was $200.00K.
- WAVE LIFE SCIENCES LTD. payments for restructuring for the quarter ending 2020-06-30 was $689.00K.
- WAVE LIFE SCIENCES LTD. payments for restructuring for the quarter ending 2020-03-31 was $2.10M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month |
|---|---|---|---|
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-09 | $889.00K derived: sum of 2 quarters · filed 2020-11-09 | $3.10M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $689.00K 10-Q · filed 2020-08-10 | $2.80M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.10M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |